May 19, 2020 / 11:56 AM / 17 days ago

BRIEF-Innovation Pharmas' Brilacidin Reduces Viral Titer Of Sars-Cov-2 (Covid-19) By 75% After Only 1 Hour Of Preincubation In In Vitro Study At Bsl-3 Facility

May 19 (Reuters) - Innovation Pharmaceuticals Inc:

* INNOVATION PHARMACEUTICALS’ BRILACIDIN REDUCES VIRAL TITER OF SARS-COV-2 (COVID-19) BY 75 PERCENT AFTER ONLY 1 HOUR OF PREINCUBATION IN IN VITRO STUDY AT BSL-3 FACILITY; DEMONSTRATES POTENT AND RAPID VIRUCIDAL ACTIVITY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below